Can a 26-year-old woman use Rituximab for chronic ITP?

Question

Hello doctor,

My 26-year-old sister was diagnosed with chronic immune thrombocytopenic purpura (ITP) last year after repeated episodes of bruising and gum bleeding. She was initially treated with steroids, but her platelet counts continue to fluctuate.

Her doctors are now considering Rituximab, but we are worried about the possible long-term side effects. We would like to understand how chronic ITP is usually managed in younger women and whether treatments like Rituximab carry risks related to infections or fertility.

Are there safer long-term treatment options if steroids are not providing stable control?

Please help.

Answer 1

Hello,

Welcome to icliniq.com.

I have read your query and understand your concern.

Chronic immune thrombocytopenic purpura (ITP) is commonly managed based on the severity of symptoms, platelet count, bleeding risk, and response to previous treatments.

In some patients with mild symptoms and moderately low platelet counts, close monitoring alone may be sufficient without immediate treatment.

Steroids are usually the first-line treatment and can help raise platelet counts temporarily.

However, when platelet levels continue to fluctuate or symptoms recur, second-line treatments such as Rituximab, intravenous immunoglobulin (IVIG), or thrombopoietin receptor agonists like Eltrombopag may be considered.

Rituximab works by suppressing the immune cells responsible for platelet destruction. It is generally well tolerated, but because it affects the immune system, there can be an increased risk of infections, particularly during and after treatment.

Regular blood count monitoring and follow-up are important throughout therapy.

Fertility problems are not commonly associated with Rituximab, and many younger women receive this treatment safely. However, pregnancy planning and future reproductive goals should still be discussed with the treating hematologist before starting therapy.

Eltrombopag is another treatment option that has shown good results in many patients with chronic ITP and may help maintain platelet counts over the long term.

The best treatment approach depends on the patient’s bleeding symptoms, platelet levels, overall health, and response to previous medications.

It is important to discuss the benefits and possible side effects of each option in detail with the treating specialist before making a decision.

I hope this helps.

Thank you.